4
Changes in Ownership
Ascendis Pharma A/S Filed Acc 0001610717-26-000177
Director bought 500 shares at an average $223.12 ($111,562)
From the SEC's structured data for this filing
Trades in this filing
BIENAIME JEAN JACQUES · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-29 | Purchase : show line 1 in the form | +200 | $223.76 | $44,752 | 600 | D |
| 2026-05-29 | Purchase : show line 2 in the form | +200 | $222.30 | $44,460 | 800 | D |
| 2026-05-29 | Purchase : show line 3 in the form | +100 | $223.50 | $22,350 | 900 | D |
| Open-market purchases · 500 sh · avg $223.12 · $111,562 | ||||||
Loading xslF345X06/form4.xml…